Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02327923Phase 4Completed
Phase 4, randomised, double-blind trial in postoperative pain comparing Lidocaine Group with Esmolol Group (2 arms). Primary endpoint: Opioid (morphine equivalent) requirement at 24 hours. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02327923.